B-cell prolymphocytic leukemia historical perspective

	B-cell prolymphocytic leukemia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
B-cell prolymphocytic leukemia historical perspective On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on B-cell prolymphocytic leukemia historical perspective
CDC on B-cell prolymphocytic leukemia historical perspective
B-cell prolymphocytic leukemia historical perspective in the news
Blogs on B-cell prolymphocytic leukemia historical perspective
Directions to Hospitals Treating B-cell prolymphocytic leukemia
Risk calculators and risk factors for B-cell prolymphocytic leukemia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Carlos A Lopez, M.D. [2]

Overview

Screening for acute lymphoblastic leukemia is not recommended.

Screening for acute lymphoblastic leukemia is not recommended.